ストックスクリーナーアプリを入手
28.44
0.44%
-0.125
前日終値:
$28.57
開ける：
$28.4
24時間の取引高:
1,060
Relative Volume:
0.19
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.62%
1か月 パフォーマンス:
-2.15%
6か月 パフォーマンス:
-5.45%
1年 パフォーマンス:
-14.54%
1日の値動き範囲:
$28.40
$28.40
1週間の範囲:
$27.48
$28.57
52週間の値動き範囲:
$25.32
$35.59
Tema Heart Health Etf Stock (HRTS) Company Profile
HRTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRTS
Tema Heart Health Etf
|
28.40 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
317.04 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.56 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
647.64 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
246.63 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.53 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Heart Health Etf (HRTS) 最新ニュース
The stock price of Novo-Nordisk A/S plummeted by nearly 22%; what happened? - 富途牛牛
Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 62.5% - Defense World
OFS Credit Company, Inc. (NASDAQ:OCCIN) Sees Significant Decline in Short Interest - Defense World
First Trust S-Network E-Commerce ETF (NASDAQ:ISHP) Short Interest Down 91.7% in July - Defense World
Northern Graphite (CVE:NGC) Shares Up 42.1% – Time to Buy? - Defense World
5 Small-cap Biotech ETFs to Watch - Investing News Network
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Investing News Network
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Declines By 28.6% - Defense World
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Down 60.0% in February - Defense World
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Why the Rich World Is Going to Need AI and Africa - Bloomberg.com
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Nasdaq
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Disruptive Theme of the Week: The Rise of Active Thematic ETFs - ETF Trends
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - markets.businessinsider.com
This ETF is trying to satisfy appetites for weight loss stocks - CNBC
ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg
Investing in the diabesity epidemic: a breakthrough moment | Opto - CMC Markets
OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace
Weight-loss drug forecasts jump to $150 billion as supply grows - Reuters
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Fighting Obesity Using ETFs - ETF Trends
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India
IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views - Investor's Business Daily
What Is a Healthcare ETF? Everything You Need to Know - ETF.com
This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch
Is the global battle against obesity an opportunity for investors? - InvestmentNews
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - Markets Insider
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily
Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering - Value The Markets
LLY Stock: Study Highlights Weight Regain Risk with Lilly's Zepbound - Value The Markets
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
The 5 Best Biotech ETFs of 2024 - etf.com
Tema Heart Health Etf (HRTS) 財務データ
Tema Heart Health Etf (HRTS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.35%
0.19%
大文字化:
|
ボリューム (24 時間):